A615 (Permax 0.05 MG)
Generic Name: pergolide
Pill with imprint A615 is Yellow, Rectangle and has been identified as Permax 0.05 MG. It is supplied by Athena.
Permax is used in the treatment of hyperprolactinemia; parkinson's disease; tourette's syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Permax 0.05 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for A615
Permax
- Generic Name:
- pergolide
- Imprint:
- A615
- Strength:
- 0.05 MG
- Color:
- Yellow
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Athena
- National Drug Code (NDC):
- 59075-0615
More about Permax (pergolide)
- Permax Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
